3 ms·

I have heard this before and believe it, but I don't understand why it's not vulnerable to a competitor (perhaps a manufacturer specialising in generic drugs)

I have heard this before and believe it, but I don't understand why it's not vulnerable to a competitor (perhaps a manufacturer specialising in generic drugs) releasing the version with only the active enantiomer. After all, it's not protected by patent.

pygy_ 9y ago
That's a very good point and I don't know either. Possibly: the process to manufacture the molecules is also patented, and you must make the racemic mix to extract the active enantiomer. Not sure though.